Correlation Between Sera Prognostics and Exagen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sera Prognostics and Exagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sera Prognostics and Exagen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sera Prognostics and Exagen Inc, you can compare the effects of market volatilities on Sera Prognostics and Exagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sera Prognostics with a short position of Exagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sera Prognostics and Exagen.

Diversification Opportunities for Sera Prognostics and Exagen

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Sera and Exagen is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Sera Prognostics and Exagen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exagen Inc and Sera Prognostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sera Prognostics are associated (or correlated) with Exagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exagen Inc has no effect on the direction of Sera Prognostics i.e., Sera Prognostics and Exagen go up and down completely randomly.

Pair Corralation between Sera Prognostics and Exagen

Given the investment horizon of 90 days Sera Prognostics is expected to under-perform the Exagen. But the stock apears to be less risky and, when comparing its historical volatility, Sera Prognostics is 1.05 times less risky than Exagen. The stock trades about -0.03 of its potential returns per unit of risk. The Exagen Inc is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  194.00  in Exagen Inc on August 24, 2024 and sell it today you would earn a total of  198.00  from holding Exagen Inc or generate 102.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sera Prognostics  vs.  Exagen Inc

 Performance 
       Timeline  
Sera Prognostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sera Prognostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Exagen Inc 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Exagen Inc are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Exagen displayed solid returns over the last few months and may actually be approaching a breakup point.

Sera Prognostics and Exagen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sera Prognostics and Exagen

The main advantage of trading using opposite Sera Prognostics and Exagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sera Prognostics position performs unexpectedly, Exagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exagen will offset losses from the drop in Exagen's long position.
The idea behind Sera Prognostics and Exagen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments